Trust the (cell manufacturing) process: Turning Research into ATMP in Flemingsberg!

Are you a practicing scientist from academia and/or industry, or simply interested in advanced therapies? We at the Flemingsberg Science Foundation warmly welcome you to the most important ATMP event of the spring!

When? March 21st
Where? Svartsjön room, Novum building, Campus Flemingsberg
Hälsovägen 7, 141 57 Huddinge

Stories of patients with long term durable responses to cell and gene therapies make headlines in the media and bring hope to patients in need of treatment options. However, getting new Advanced Therapy Medicinal Products (ATMPs) from the research lab to the reality of the patient bedside, relies not only on a robust and scalable cell manufacturing process, but also on successful navigation of the regulatory environment and an engaged and supportive ATMP community.

As stakeholders with a shared vision of creating momentum in accelerating access to ATMPs in the Nordics, Flemingsberg Science Foundation, Karolinska ATMP-centrum and Miltenyi Biotec Nordics are proud to host an educational seminar aimed at highlighting challenges and opportunities in getting new ATMPs from concept to clinic. Join Nordic cell therapy experts and enthusiasts in uniting towards bringing more ATMP options to more patients, more efficiently.

Welcome!

Speakers:
Johnny Högberg
Matti Sallberg
Pontus Blomberg
Stephan Mielke
Gustaf Ahlén
Di Yu
Stina Wickström
Nikola Vojnovic

Register here

Partners
Karolinska Universitetssjukhuset
Karolinska Institutet
Miltenyi Biotec
Elicera Therapeutics AB
ATMP Sweden

Published On: 8 February 2024

  • Cecilia Bergh: “We’ll succeed – it just needs hard work”

    After almost 25 years’ concerted struggle to disseminate her successful eating disorder treatment, Cecilia Bergh wants to shift up a gear. Her goal is to digitalise her technique and turn the Mandometer support tool into a consumer product.

  • Chris Heister: “Everyone who has made this journey feels as though they’re fighting the system a bit.”

    Even if Chris Heister shifts down a gear when she leaves her role as council leader in Stockholm, she is unlikely be drawing on her pension any time soon. The class journey she has made from growing up in a countryside idyll, north of Stockholm, has given her a momentum that continually drives her forward.

  • Evren Alici set to make cancer a liveable illness

    A recent study could pave the way to treating a type of bone marrow cancer. The aim is to transform the cancer from being incurable to a disease that it is possible to live with. The research behind the study was conducted in Evren Alici’s group at Campus Flemingsberg.

  • Karin Mellström: “Co-operation is the key to success”

    After 10 years as a start-up, CellProtect Nordic Pharmaceuticals has taken a major step forward. Our patient and careful work is now bearing fruit, explains Karin Mellström, CEO and founder. Looking back on her career, she sums it up by saying: “I’d never been bored for a second!”

  • Matti Sällberg: “Vital to contribute facts to the debate”

    During the course of the pandemic, he has appeared on an almost daily basis in the morning papers or on the TV news. Matti Sällberg fast became an expert the media called for help explaining everything from vaccine development to the spread of infection.